✦ LIBER ✦

Erectile dysfunction after prostate three-dimensional conformal radiation therapy

✍ Scribed by Magli, A.; Giangreco, M.; Crespi, M.; Negri, A.; Ceschia, T.; Giorgi, G.; Titone, F.; Parisi, G.; Fongione, S.

Book ID: 118778498
Publisher: Springer
Year: 2012
Tongue: German
Weight: 400 KB
Volume: 188
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-012-0227-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erectile dysfunction and radiation thera

Erectile dysfunction and radiation therapy for prostate cancer

✍ L. Incrocci 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Three-dimensional conformal radiation th

Three-dimensional conformal radiation therapy for ependymoma

✍ Thomas E. Merchant 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Sildenafil citrate effectively reverses

Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy

✍ Richard K Valicenti; Eugene Choi; Chris Chen; J.D Lu; Irvin H Hirsch; Grant S Mu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Coping with prostate and seminal vesicle

Coping with prostate and seminal vesicle motion in three-dimensional conformal radiation therapy

✍ Steven A. Leibel; Gerald J. Kutcher; Michael J. Zelefsky; Zvl Fuks 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Variation in prostate position: Quantita

Variation in prostate position: Quantitation and implications for three-dimensional conformal radiation therapy

✍ Edward Melian; Gerald Kutcher; Steven Leibel; Michael Zelefsky; Bernard Baldwin; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Validation of a treatment policy for pat

Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy

✍ Wayne H. Pinover; Eric M. Horwitz; Alexandra L. Hanlon; Robert G. Uzzo; Gerald E 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this report was to present an outcomes validation for the Fox Chase Cancer Center (FCCC) management policy for patients who demonstrate prostate specific antigen (PSA) failure after receiving three‐dimensional conformal radiation therapy (3DCRT). ## METH